A US appeals court docket dominated on Wednesday to limit entry to the abortion capsule mifepristone, partially upholding a decrease court docket ruling that alarmed abortion advocates and pharmaceutical firms.

The New Orleans-based fifth US Circuit Court of Appeals dominated to dam modifications that made the drug extra accessible, however reversed a decrease court docket ruling that suspended the drug’s approval in 2000.

Mifepristone’s availability stays unchanged for now, following an emergency order from the US Supreme Court in April preserving the established order throughout the attraction.